Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Agilent Technologies, Inc. (A) Insider Trading Activity
Healthcare • Diagnostics & Research • 17,400 employees
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Total Value
$3,622,704.34
Total Shares
28,197
Average Trade Value
$95,334.32
Most Active Insider
Mcdonnell Padraig
Total Activity: $3,646,668
Largest Single Transaction
$2,162,720
by Mcdonnell Padraig on Nov 27, 2024
30-Day Activity
1 Transaction
Volume: 1,911 shares
Value: $286,650
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
---|---|---|---|---|---|---|
President and CEO
Director, Officer
|
Jan 21, 2025 | 1,911 | $286,650 | 39,652 (-4.8%) | Sale | |
Sr Vice President
Officer
|
Nov 29, 2024 | 2,577 | $355,549 | 88,097 (-2.9%) | Payment of Exercise Price | |
Senior Vice President
|
Nov 27, 2024 | 3,212 | $443,706 | 19,054 (+16.9%) | Grant | |
Senior Vice President
|
Nov 27, 2024 | 2,569 | $354,882 | 5,796 (+44.3%) | Grant | |
President and CEO
|
Nov 27, 2024 | 15,656 | $2,162,720 | 41,563 (+37.7%) | Grant | |
Senior Vice President
|
Nov 27, 2024 | 3,212 | $443,706 | 8,313 (+38.6%) | Grant | |
Senior Vice President
|
Nov 27, 2024 | 3,814 | $526,866 | 5,432 (+70.2%) | Grant | |
Sr. Vice President
|
Nov 27, 2024 | 4,336 | $598,975 | 90,674 (+4.8%) | Grant | |
Senior Vice President
|
Nov 27, 2024 | 3,452 | $476,859 | 7,687 (+44.9%) | Grant | |
V.p., Corporate Controller
|
Nov 27, 2024 | 1,365 | $188,561 | 23,671 (+5.8%) | Grant | |
Sr. VP and CFO
|
Nov 27, 2024 | 6,423 | $887,273 | 166,762 (+3.9%) | Grant | |
Sr. VP and CFO
Officer
|
Nov 22, 2024 | 5,775 | $772,926 | 160,339 (-3.6%) | Payment of Exercise Price | |
Senior Vice President
Officer
|
Nov 22, 2024 | 54 | $7,227 | 15,842 (-0.3%) | Payment of Exercise Price | |
Sr Vice President
Officer
|
Nov 22, 2024 | 581 | $77,761 | 86,338 (-0.7%) | Payment of Exercise Price | |
President and CEO
Director, Officer
|
Nov 22, 2024 | 448 | $59,960 | 25,907 (-1.7%) | Payment of Exercise Price | |
Senior Vice President
Officer
|
Nov 22, 2024 | 113 | $15,124 | 5,101 (-2.2%) | Payment of Exercise Price | |
V.p., Corporate Controller
Officer
|
Nov 22, 2024 | 138 | $18,470 | 22,306 (-0.6%) | Payment of Exercise Price | |
Senior Vice President
Officer
|
Nov 22, 2024 | 65 | $8,700 | 3,227 (-2.0%) | Payment of Exercise Price | |
Sr. VP and CFO
Officer
|
Nov 19, 2024 | 2,196 | $276,015 | 166,114 (-1.3%) | Payment of Exercise Price | |
President and CEO
Director, Officer
|
Nov 19, 2024 | 4,505 | $566,233 | 27,861 (+16.2%) | Grant | |
Sr Vice President
Officer
|
Nov 19, 2024 | 2,991 | $375,939 | 86,919 (-3.4%) | Payment of Exercise Price | |
President and CEO
Director, Officer
|
Nov 19, 2024 | 1,506 | $189,289 | 26,355 (-5.7%) | Payment of Exercise Price | |
Senior Vice President
Officer
|
Nov 19, 2024 | 653 | $82,076 | 10,650 (+6.1%) | Grant | |
Sr. VP and CFO
Officer
|
Nov 19, 2024 | 7,835 | $984,781 | 168,310 (+4.7%) | Grant | |
V.p., Corporate Controller
Officer
|
Nov 19, 2024 | 1,698 | $213,422 | 23,035 (+7.4%) | Grant | |
Senior Vice President
Officer
|
Nov 19, 2024 | 1,045 | $131,346 | 16,223 (+6.4%) | Grant | |
Senior Vice President
Officer
|
Nov 19, 2024 | 327 | $41,101 | 15,896 (-2.1%) | Payment of Exercise Price | |
Sr Vice President
Officer
|
Nov 19, 2024 | 7,954 | $999,738 | 89,910 (+8.8%) | Grant | |
V.p., Corporate Controller
Officer
|
Nov 19, 2024 | 591 | $74,283 | 22,444 (-2.6%) | Payment of Exercise Price | |
President and CEO
Director, Officer
|
Nov 15, 2024 | 715 | $90,855 | 23,356 (-3.1%) | Payment of Exercise Price | |
V.p., Corporate Controller
Officer
|
Nov 15, 2024 | 276 | $35,071 | 21,337 (-1.3%) | Payment of Exercise Price | |
Sr Vice President
Officer
|
Nov 15, 2024 | 796 | $101,148 | 81,956 (-1.0%) | Payment of Exercise Price | |
Senior Vice President
Officer
|
Nov 15, 2024 | 172 | $21,856 | 15,178 (-1.1%) | Payment of Exercise Price | |
Sr. VP and CFO
Officer
|
Nov 15, 2024 | 1,295 | $164,556 | 160,475 (-0.8%) | Payment of Exercise Price | |
President and CEO
Director, Officer
|
Sep 27, 2024 | 47 | $7,050 | 24,071 (-0.2%) | Sale | |
Senior Vice President
Officer
|
Sep 26, 2024 | 5,010 | $726,450 | 46,761 (-10.7%) | Sale | |
Senior Vice President
Officer
|
Sep 26, 2024 | 9,990 | $1,448,550 | 40,010 (-25.0%) | Sale | |
President and CEO
Director, Officer
|
Aug 22, 2024 | 1,958 | $283,910 | 24,118 (-8.1%) | Sale |